[1] Zhang S, Cai M, Meng X, et al.Sources apportionment and carcinogenic risk of polycyclic aromatic hydrocarbons in gas phase of urban Shanghai: Based on high volume solid phase extraction (Hi-volume SPE)[J]. Ecotoxicol Environ Saf, 2020, 195(1): 1-7. [2] Mallah MA, Changxing L, Mallah MA, et al.Polycyclic aromatic hydrocarbon and its effects on human health: An overeview[J]. Chemosphere, 2022, 296(1): 1-16. [3] Hsu SC, Chang JH, Lee CL, et al.Differential time-lag effects of ambient PM2.5 and PM2.5-bound PAHs on asthma emergency department visits[J]. Environ Sci Pollut Res Int, 2020, 27(34): 43117-43124. [4] Barbosa FJr, Rocha BA, Souza MCO, et al.Polycyclic aromatic hydrocarbons (PAHs): Updated aspects of their determination, kinetics in the human body, and toxicity[J]. J Toxicol Environ Health B Crit Rev, 2023, 26(1): 28-65. [5] Jedrychowski WA, Majewska R, Spengler JD, et al.Prenatal exposure to fine particles and polycyclic aromatic hydrocarbons and birth outcomes: A two-pollutant approach[J]. Int Arch Occup Environ Health, 2017, 90(3): 255-264. [6] Akhbarizadeh R, Dobaradaran S, Amouei Torkmahalleh M, et al.Suspended fine particulate matter (PM2.5), microplastics (MPs), and polycyclic aromatic hydrocarbons (PAHs) in air: Their possible relationships and health implications[J]. Environ Res, 2021, 192(1): 1-12. [7] Goudarzi G, Baboli Z, Moslemnia M, et al.Assessment of incremental lifetime cancer risks of ambient air PM10-bound PAHs in oil-rich cities of Iran[J]. J Environ Health Sci Eng, 2021, 19(1): 319-330. [8] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures[J]. IARC Monogr Eval Carcinog Risks Hum, 2010, 92: 1-853. [9] 李文静,张美云,万博宇,等. 北京市朝阳区大气PM2.5中多环芳烃的污染特征及健康风险评估[J]. 职业与健康,2021,37(16):2235-2238,2242. [10] 曹萌,王丽珩,彭秀苗,等. 2016—2020年济南市两城区大气PM2.5中多环芳烃浓度特征及慢性健康风险评估[J]. 山东大学学报(医学版),2021,59(12):87-95. [11] 唐大镜,孙成瑶,陈凤格,等. 石家庄市采暖期与非采暖期PM2.5中多环芳烃的来源解析及健康风险评价[J]. 气象学报,2022,80(3):410-420. [12] 葛成相,沈彤,张霞,等. 合肥市大气PM2.5中多环芳烃分布特征、源解析及致癌风险评价[J]. 环境卫生学杂志,2023,13(3):204-212. [13] Office of Super Fund Remediation and Technology Innovation, Environmental Protection Agency. Risk assessment guidance for super fund Volume I human health evaluation manual (Part F, Supplemental guidance for inhalation risk assessment, EPA -540-R-070-002, OSWER 9285.7-82 January 2009)[J]. Washington: US.Environmental Protection Agency, 2009. [14] 中华人民共和国国家卫生健康委员会. 大气污染人群健康风险评估技术规范:WS/T 666—2019[S]. 北京:中国标准出版社,2019:19-22. [15] 黄楠,王贝贝,钱岩,等. 多环芳烃呼吸暴露的健康风险评估研究进展[J]. 环境与可待持续发展,2011,36(1):1-4. [16] Nisbet IC, LaGoy PK. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs)[J]. RTP, 1992, 16(3): 290-300. [17] US EPA. Regional screening levels(RSLs) generic tables[EB/OL]. (2020-11-01)[2023-11-21]. https//www.epa.gov/risk/regional-screening-levels-rsls-generic-tables. [18] Integrated Risk Information System, National Center For Environmental Assessment, Office of Research and Development, U.S.Environmental Protection Agency. Toxicological review of Benzo[a]pyrene executive summary (EPA/635/R-17/003Fc)[R]. Washington: U.S.Environmental Protection Agency, 2017. [19] 吴和岩,黄利群,宁婷,等. 珠海市2017—2018大气PM2.5污染成份特征及金属元素来源解析[J]. 现代预防医学,2022,49(1):27-31. [20] 吴和岩,谭爱军,黄利群,等. 珠海市大气PM2.5与儿科呼吸系统疾病门诊日就诊人次的关系研究[J]. 环境与健康杂志,2018(11):973-976. [21] 陈超,郭庶,李文胜,等.惠州市大气PM2.5中Cr、As、V污染特征与健康风险评价[J]. 热带医学杂志,2021,21(2):243-247. [22] 肖雪花,曾小鹏,王彦硕,等. 佛山市禅城区PM2.5成分分析及污染特征研究[J]. 中国卫生检验杂志,2023,33(6):729-733. [23] 葛成相,沈彤,张霞,等. 合肥市大气PM2.5中多环芳烃分布特征、源解析及致癌风险评价[J]. 环境卫生学杂志,2023,13(3):204-212. [24] 罗馨雨,刘宝林,刘思序,等. 长春市秋、冬季大气PM2.5中多环芳烃污染特征及致癌风险评价[J]. 长春师范大学学报,2023,42(2):191-195. [25] 李盛,王金玉,高青,等. 2019─2020年兰州市两城区大气多环芳烃污染特征、来源与健康风险评估[J]. 环境与职业医学,2022,39(11):1269-1276. |